-
-
-
-
-
-
-
Johnson & Johnson reports nipocalimab shows stronger response in Sjögren's patients
-
-
-
-
-
-
-
Johnson & Johnson launches Shockwave C2 Aero coronary catheter globally
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) to start marketing 4 meds on TrumpRX - CBS
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) PT Raised to $250 at Stifel on Beat and Raise Performance
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) Raises Quarterly Dividend 3.1% to $1.34; 2.3% Yield
-
-
-
-
-
-
-
Johnson & Johnson launches VARIPULSE Pro in Europe with CE Mark approval
-
-
-
-
-
-
-
BofA Securities remains Neutral on Johnson & Johnson (JNJ): early Ico approval was 'modest upside'
-
413,947 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

